Arena Pharmaceuticals, Inc. (ARNA): Price and Financial Metrics
Arena Pharmaceuticals, Inc. (ARNA)
Today's Latest Price: $44.51 USD
1.30 (-2.84%)
Updated Jan 24 5:20pm
Add ARNA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ARNA Stock Summary
- ARNA's current price/earnings ratio is 4.08, which is higher than just 3.89% of US stocks with positive earnings.
- Over the past twelve months, ARNA has reported earnings growth of -628.2%, putting it ahead of just 2.41% of US stocks in our set.
- Revenue growth over the past 12 months for Arena Pharmaceuticals Inc comes in at 8,363.54%, a number that bests 99.88% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Arena Pharmaceuticals Inc are RGLS, STML, AEZS, PULM, and SHIP.
- ARNA's SEC filings can be seen here. And to visit Arena Pharmaceuticals Inc's official web site, go to www.arenapharm.com.
ARNA Daily Price Range
ARNA 52-Week Price Range
ARNA Stock Price Chart More Charts
ARNA Price/Volume Stats
| Current price | $44.51 | 52-week high | $64.48 |
| Prev. close | $45.81 | 52-week low | $42.48 |
| Day low | $44.25 | Volume | 533,510 |
| Day high | $46.34 | Avg. volume | 455,181 |
| 50-day MA | $46.46 | Dividend yield | N/A |
| 200-day MA | $51.40 | Market Cap | 2.23B |
Arena Pharmaceuticals, Inc. (ARNA) Company Bio
Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing drugs to address unmet medical needs. The company was founded in 1997 and is based in San Diego, California.
Top Stories View All
1 Equation Keeps the Bear Market in Hibernation
Best & Worst Performing Stock Industries for January 24, 2020
Best & Worst Performing Small Cap Stocks for January 24, 2020
Best & Worst Performing Mid Cap Stocks for January 24, 2020
Best & Worst Performing Large Cap Stocks for January 24, 2020
View All Top Stories
Loading social stream, please wait...